<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Astrogen, inc. Latest Press Releases</title>
<link>https://pressroom.prlog.org/astrogen/</link>
<description>About Astrogen, inc. - Astrogen, inc. is a ventured backed clinical-stage biotech company based in South Korea developing small-molecule therapies for neurological and rare diseases, with AST-001 as a lead program for autism spectrum disorder.</description>
<item><title>Astrogen and Cigalah Sign Exclusive MENA Partnership for AST-001</title>
<link>https://www.prlog.org/13120144-astrogen-and-cigalah-sign-exclusive-mena-partnership-for-ast-001.html</link>
<description>Astrogen and Cigalah partner to bring AST-001, a first-in-class ASD treatment, to 16 MENA markets via a US$209M deal including local manufacturing and technology transfer</description><pubDate>Wed, 07 Jan 2026 02:11:50 GMT</pubDate></item>
</channel>
</rss>